Bjorn Gudbjornsson Selected Research

Bjorn Gudbjornsson Research Topics

Disease

20	Psoriatic Arthritis 04/2024 - 11/2014
15	Rheumatoid Arthritis 03/2024 - 01/2017
10	Axial Spondyloarthritis 01/2024 - 01/2020
9	Pain (Aches) 01/2024 - 12/2016
8	Ankylosing Spondylitis 09/2023 - 05/2010
7	Fatigue 01/2024 - 01/2018
4	Arthritis (Polyarthritis) 02/2023 - 09/2013
3	Necrosis 01/2023 - 01/2021
2	Osteoporosis 01/2024 - 01/2002
2	Rheumatic Diseases (Rheumatism) 02/2023 - 01/2017
2	Neoplasms (Cancer) 12/2022 - 01/2021
2	Inflammation (Inflammations) 01/2022 - 01/2022
2	Joint Diseases (Joint Disease) 01/2020 - 09/2013
1	Infections 01/2023
1	Multiple Sclerosis 01/2023
1	Demyelinating Diseases (Demyelinating Disease) 01/2023
1	Polyneuropathies (Polyneuropathy) 01/2023
1	Non-Radiographic Axial Spondyloarthritis 01/2023
1	Spondylarthritis (Spinal Arthritis) 11/2022
1	Autoimmune Hepatitis 01/2022
1	Acute Coronary Syndrome 01/2022
1	Chemical and Drug Induced Liver Injury 01/2022
1	COVID-19 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Reactive Arthritis (Reiter Disease) 10/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020
1	Thyroid Diseases (Thyroid Disease) 01/2020
1	Premature Birth (Birth, Premature) 01/2019
1	Gouty Arthritis 04/2018
1	Body Weight (Weight, Body) 11/2014
1	Cerebral Infarction 06/2010
1	Myocardial Infarction 06/2010
1	Unstable Angina 06/2010

Drug/Important Bio-Agent (IBA)

19	Tumor Necrosis Factor InhibitorsIBA 04/2024 - 01/2019
11	Antirheumatic Agents (DMARD)IBA 03/2024 - 01/2017
7	secukinumabIBA 01/2024 - 01/2020
6	C-Reactive ProteinIBA 09/2023 - 01/2018
5	ametantrone (HAQ)IBA 01/2024 - 01/2019
4	Methotrexate (Mexate)FDA LinkGeneric 10/2023 - 12/2020
4	Abatacept (Orencia)FDA Link 10/2023 - 12/2020
4	Infliximab (Remicade)FDA Link 01/2022 - 11/2014
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024 - 01/2002
3	Etanercept (Enbrel)FDA Link 01/2023 - 01/2018
3	Adalimumab (Humira)FDA Link 01/2023 - 01/2018
3	amsonic acid (DAS)IBA 01/2020 - 12/2016
2	Prostaglandins AIBA 01/2024 - 11/2022
2	GlucocorticoidsIBA 01/2024 - 01/2017
2	Certolizumab Pegol FDA Link 10/2023 - 10/2022
2	tocilizumab (atlizumab)FDA Link 10/2023 - 10/2022
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022 - 02/2022
2	ORALIT (ORS)IBA 01/2022 - 01/2021
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2022 - 05/2010
2	Anti-Citrullinated Protein AntibodiesIBA 12/2020 - 01/2020
2	Rheumatoid FactorIBA 12/2020 - 01/2020
1	ProstaglandinsIBA 03/2024
1	SteroidsIBA 01/2024
1	AntibodiesIBA 01/2023
1	tofacitinibIBA 01/2023
1	apremilastIBA 01/2023
1	ixekizumabIBA 01/2023
1	Ustekinumab (CNTO 1275)FDA Link 01/2023
1	insulin receptor-related receptor (IRR)IBA 12/2022
1	ChemokinesIBA 07/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	HLA-B Antigens (HLA-B)IBA 07/2021
1	Interferon-alpha (Interferon Alfa)IBA 01/2021
1	AutoantibodiesIBA 01/2021
1	Interferon Type IIBA 01/2021
1	flt3 ligand protein (flt3 ligand)IBA 01/2020
1	Uric Acid (Urate)IBA 04/2018
1	HLA-B14 AntigenIBA 09/2013
1	AntigensIBA 09/2013
1	HLA-B8 Antigen (HLA B8 Antigen)IBA 09/2013
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2013
1	HLA-A11 AntigenIBA 09/2013
1	Diclofenac (SR 38)FDA LinkGeneric 06/2010
1	Ibuprofen (Motrin)FDA LinkGeneric 06/2010
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 06/2010
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 06/2010
1	Naproxen (Naprosyn)FDA LinkGeneric 06/2010
1	rofecoxib (Vioxx)FDA Link 06/2010

Therapy/Procedure

5	Therapeutics 10/2023 - 01/2002
1	Aftercare (After-Treatment) 02/2022
1	Cesarean Section (Caesarean Section) 01/2019